Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalized Therapy of Sarcomas.
Desar IME, Rothermundt C. Desar IME, et al. Cancers (Basel). 2023 Oct 23;15(20):5110. doi: 10.3390/cancers15205110. Cancers (Basel). 2023. PMID: 37894477 Free PMC article.
Pharmacokinetics of sunitinib in an obese patient with a GIST.
Desar IM, Burger DM, Van Hoesel QG, Beijnen JH, Van Herpen CM, Van der Graaf WT. Desar IM, et al. Ann Oncol. 2009 Mar;20(3):599-600. doi: 10.1093/annonc/mdn779. Epub 2009 Jan 19. Ann Oncol. 2009. PMID: 19153120 Free article. No abstract available.
Corrigendum to 'Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients' [Eur J Cancer 141 (2020) 128-136].
Acem I, Verhoef C, Rueten-Budde AJ, Grünhagen DJ, van Houdt WJ, van de Sande MAJ; PERSARC study group. Acem I, et al. Eur J Cancer. 2022 Feb;162:247-249. doi: 10.1016/j.ejca.2021.12.002. Epub 2021 Dec 31. Eur J Cancer. 2022. PMID: 34980501 Free article. No abstract available.
The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.
Banerji U, Camidge DR, Verheul HM, Agarwal R, Sarker D, Kaye SB, Desar IM, Timmer-Bonte JN, Eckhardt SG, Lewis KD, Brown KH, Cantarini MV, Morris C, George SM, Smith PD, van Herpen CM. Banerji U, et al. Clin Cancer Res. 2010 Mar 1;16(5):1613-23. doi: 10.1158/1078-0432.CCR-09-2483. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179232 Free article. Clinical Trial.
Kidney injury during VEGF inhibitor therapy.
den Deurwaarder ES, Desar IM, Steenbergen EJ, Mulders PF, Wetzels JF, van Herpen CM. den Deurwaarder ES, et al. Neth J Med. 2012 Aug;70(6):267-71. Neth J Med. 2012. PMID: 22859418 Free article. Review.
Unraveling the Heterogeneity of Sarcoma Survivors' Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study.
van Eck I, den Hollander D, Desar IME, Soomers VLMN, van de Sande MAJ, de Haan JJ, Verhoef C, Vriens IJH, Bonenkamp JJ, van der Graaf WTA, van Houdt WJ, Husson O. van Eck I, et al. Among authors: desar ime. Cancers (Basel). 2020 Oct 22;12(11):3083. doi: 10.3390/cancers12113083. Cancers (Basel). 2020. PMID: 33105807 Free PMC article.
143 results